Rentschler Biopharma

Rentschler Biopharma: ‘Our strength is in our niche’

15-Jun-2023 By Isabel Cameron

As the global contract development and manufacturing organization (CDMO) market continues to grow, we caught up with Federico Pollano, SVP business development at Rentschler Biopharma, at Bio International 2023, to discuss the company's ongoing growth...

Vetter and Rentschler progress joint CDMO collaborative work

04-Apr-2022 By Jane Byrne

Vetter and Rentschler Biopharma are looking to boost the awareness and benefits of their strategic CDMO alliance.

Rentschler and Vetter cooperate to integrate services

09-Jul-2020 By Ben Hargreaves

The CDMOs will launch pilot projects to determine where collaboration may help streamline drug development.

Rentschler enters agreement with Genmab for antibody manufacture

04-Jun-2020 By Ben Hargreaves

Rentschler will manufacture Genmab’s bispecific antibodies and expand the US site where the work will take place.

Biologics CDMO buys Shire Massachusetts facility

02-Jan-2019 By Staff Reporter

Rentschler Biopharma will buy Shire’s development and manufacturing facility in Milton, Massachusetts, where the latter makes haemophilia A product, Obizur, for commercial production.